Đang chuẩn bị liên kết để tải về tài liệu:
Multinomial network meta‑analysis using response rates: Relapsed/refractory multiple myeloma treatment rankings differ depending on the choice of outcome

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Due to the fast-growing relapsed/refractory multiple myeloma (RRMM) treatment landscape, a comparison of all the available treatments was warranted. For clinical practice it is important to consider both immediate effects such as response quality and prolonged benefits such as progression-free survival (PFS) in a meta-analysis. The objective of this study was to assess the impact of the choice of outcome on the treatment rankings in RRMM. |